Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Saturday, January 13, 2018 At 10:00 A.M. At The Registered Office Of The Company

 We wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, January 13, 2018 at 10:00 A.M. at the Registered Office of the Company; interalia to consider and approve the allotment of 4,99,999 Equity Shares in reference to the In-principal Approval Letter received by the Company.
10-01-2018
Bigul

Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Saturday, January 13, 2018 At 10:00 A.M. At The Registered Office Of The Company

 We wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, January 13, 2018 at 10:00 A.M. at the Registered Office of the Company; interalia to consider and approve the allotment of 4,99,999 Equity Shares in reference to the In-principal Approval Letter received by the Company.
10-01-2018
Bigul

Statement Of Investors Grievances For The Quarter Ended December 31, 2017

 In compliance to Regulation 13(3) of SEBI Listing Regulations, 2015; we furnish a statement of Investors Grievances for the quarter ended December 31, 2017.
08-01-2018
Bigul

Newspaper Publication

 In compliance to Regulation 47 of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Unaudited Financial Results of the Company for Quarter & Half year ended September 30, 2017; as approved by the Board in its meeting held on Monday, November 13, 2017; published in Navshakti & Free-press Journal on November 14, 2017.
14-11-2017
Bigul

Financials Result For The Quarter & Half Year Ended September 30, 2017.

 In reference to our letter to BSE on November 13, 2017 i.e., Outcome of Board Meeting; please find attached herewith the Unaudited Financial Results of Fredun Pharmaceuticals Limited as approved by the Board of Directors in there Meeting Held on November 13, 2017, along with the Limited Review Report & Reconciliation Report as required under Ind-As.
14-11-2017
Bigul

Updates

 Pursuant to Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015; the Board in its Meeting held on Monday, November 13, 2017 has adopted the Fredun Pharmaceuticals Limited 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information'.
13-11-2017
Bigul

Outcome of Board Meeting

 In compliance to Regulation 33 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of the Company, at its Meeting held on Monday, November 13, 2017, have considered and approved the Unaudited Financial Results of the Company for Quarter & Half year ended September 30, 2017 along with the Limited Review Report issued by M/s. Savla & Associates, Statutory Auditors of the Company.
13-11-2017
Bigul

Updates

 Pursuant to Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015; the Board in its Meeting held on Monday, November 13, 2017 has adopted the Fredun Pharmaceuticals Limited 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information'.
13-11-2017
Bigul

Outcome of Board Meeting

 In compliance to Regulation 33 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of the Company, at its Meeting held on Monday, November 13, 2017, have considered and approved the Unaudited Financial Results of the Company for Quarter & Half year ended September 30, 2017 along with the Limited Review Report issued by M/s. Savla & Associates, Statutory Auditors of the Company.
13-11-2017
Bigul

Intimation Of The Board Meeting & Trading Window Closure.

 Pursuant to Regulation 29 of SEBI Listing Regulations, 2015 we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 13, 2017 at 2:00 P.M. at the Registered Office of the Company inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half year ended September 30, 2017.
04-11-2017
Next Page
Close

Let's Open Free Demat Account